Oppenheimer Reiterates Outperform Rating for Xylem (NYSE:XYL)

Xylem (NYSE:XYL)‘s stock had its “outperform” rating reissued by analysts at Oppenheimer in a research report issued on Wednesday,Benzinga reports. They currently have a $160.00 price target on the industrial products company’s stock, down from their prior price target of $165.00. Oppenheimer’s target price suggests a potential upside of 30.34% from the stock’s current price.

XYL has been the subject of a number of other reports. Stifel Nicolaus cut their target price on shares of Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. TD Cowen reiterated a “hold” rating on shares of Xylem in a research report on Monday, February 23rd. William Blair initiated coverage on shares of Xylem in a research note on Monday, January 26th. They issued an “outperform” rating for the company. Wall Street Zen downgraded shares of Xylem from a “buy” rating to a “hold” rating in a report on Saturday, December 27th. Finally, UBS Group restated a “buy” rating and set a $155.00 target price on shares of Xylem in a research report on Friday, February 13th. Ten analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.54.

Xylem Price Performance

Shares of NYSE:XYL traded up $3.26 during mid-day trading on Wednesday, reaching $122.76. The stock had a trading volume of 677,495 shares, compared to its average volume of 1,850,426. The business’s 50 day moving average price is $128.81 and its 200 day moving average price is $138.08. Xylem has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a market cap of $29.85 billion, a P/E ratio of 31.33, a price-to-earnings-growth ratio of 1.66 and a beta of 1.17. The company has a current ratio of 1.62, a quick ratio of 1.28 and a debt-to-equity ratio of 0.12.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, meeting the consensus estimate of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.Xylem’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Research analysts expect that Xylem will post 4.65 EPS for the current fiscal year.

Xylem announced that its Board of Directors has initiated a share repurchase program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. J. Stern & Co. LLP lifted its holdings in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Norges Bank purchased a new stake in Xylem in the 4th quarter worth about $361,012,000. Schroder Investment Management Group lifted its stake in Xylem by 2,055.2% in the third quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company’s stock worth $171,687,000 after purchasing an additional 1,137,342 shares during the last quarter. Swedbank AB lifted its stake in Xylem by 19.0% in the third quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after purchasing an additional 830,821 shares during the last quarter. Finally, Amundi boosted its position in shares of Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after buying an additional 830,337 shares during the period. Institutional investors own 87.96% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.